Dexcom Inc. secured $7.2 million from the investors according to the SEC form registered.
Fruit Street Health, a telehealth startup with a joint venture with VSee, has raised $5.4 million in the past year from 120 physicians a crowdfunding push, according to an amended Form D filing with the U.S. Securities and Trade Commission. In November, Fruit Street announced it had raised $4 million from 60 physicians. The amended filing shows it has raised an additional $1.4 million since then from 50 more doctors.
Japanese devicemaker Terumo has been awarded $17.4 million in initial funding from the U.S. government to study its Mirasol pathogen reduction system for the treatment of patients with hypoproliferative thrombocytopenia.
San Francisco-based FareWell has raised $8.5 million for an online program aimed at preventing chronic diseases by addressing obesity as a root cause. The funding comes from individual investors including David Perry, the company's cofounder and chairman.
Teladoc, Inc. (NYSE:TDOC), the first and largest telehealth platform in the United States, today announced that it has entered into a $25 million term loan and $25 million revolving line of credit agreement with Silicon Valley Bank (SVB), the bank of the world’s most innovative companies and their investors. This agreement provides up to $50 million of new capital to the company to be used for general corporate purposes.
Teladoc, Inc. registered a SEC form stating $80 million funding from the investors in an equity round.
Senseonics (NYSE:SENS) said yesterday that it took out a term loan worth $30 million from Oxford Finance and Silicon Valley Bank, augmenting the $45 million it raised in an initial public offering in March.
Beta Bionics, company creating an “artificial pancreas” for diabetics, this week became the first startup to raise $1 million using new type of online stock sale open to the public at large. The startup created by Boston University biomedical engineer Ed Damiano, hit the benchmark Wednesday night after 775 members of the public put up an average of $1,300 each to back its idea for a new kind of pacemaker for diabetics.
MyWay Diabetes is granted the prize of £899,792 from the SBRI Healthcare.
Hedia has landed its first investment of half a million kroner, which over the next few months will turn the startup's idea into a fully functional product. The investment is a so-called Discovery loan from PSI/SEED, which is a strategic collaboration between the innovation environment Pre-Seed Innovation and SEED Capital .